发现好书期刊，享受阅读乐趣

海量图书期刊资源，随时随地畅享阅读乐趣

Cost-Utility Analysis of First-Line Gefitinib, Erlotinib and Afatinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations

Cost-Utility Analysis of First-Line Gefitinib, Erlotinib and Afatinib in Patients with Non-Small Cell Lung Cancer Harboring EGFR Mutations

Holleman, MS; Zaim, R; Uyl-De Groot, CA

期刊名称Value in Health
作者Holleman, MS; Zaim, R; Uyl-De Groot, CA
卷第19卷
期第7期
印刷ISSN1098-3015
文件大小90.80KB
发表时间2016-11
DOI10.1016/j.jval.2016.09.2253

← 返回【学霸图书馆】主页